ZBIO · Categories · Form 4

ZBIO - SEC Form 4 insider transactions

Zenas BioPharma Inc. (ZBIO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ZBIO

• 69d
  SEC Form 4 filed by Lu Hongbo

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 70d
  SEC Form 4 filed by Fairmount Funds Management Llc

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 71d
  SEC Form 4 filed by Moulder Leon O Jr

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 71d
  SEC Form 4 filed by Lu Hongbo

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 363d
  SEC Form 4 filed by Director Nunn Jason Raleigh

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 363d
  SEC Form 4 filed by Officer Fox Jennifer A.

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 363d
  SEC Form 4 filed by Officer Oliveira Orlando

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 363d
  SEC Form 4 filed by Director Boylan James P

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 363d
  SEC Form 4 filed by Director Allen Patricia L

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 363d
  SEC Form 4 filed by Officer Farmer Joseph L

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 363d
  SEC Form 4 filed by Director Fairmount Funds Management Llc

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 363d
  SEC Form 4 filed by Director Enright Patrick G

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 363d
  SEC Form 4 filed by Director Orloff John J

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 363d
  SEC Form 4 filed by Director Lu Hongbo

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 363d
  SEC Form 4 filed by Officer Moulder Leon O Jr

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 419d
  SEC Form 4 filed by Officer Von Moltke Lisa

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 539d
  SEC Form 4 filed by Officer Fox Jennifer A.

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 539d
  SEC Form 4 filed by Chief Commercial Officer Oliveira Orlando

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 631d
  Amendment: Chief Executive Officer Moulder Leon O Jr converted options into 693,175 shares, increasing direct ownership by 3,465% to 161,155 units (SEC Form 4)

  4/A - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 632d
  SEC Form 4 filed by Director Orloff John J

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 632d
  SEC Form 4 filed by Director Xiao Ting

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 632d
  SEC Form 4 filed by Director Lu Hongbo

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 632d
  SEC Form 4 filed by Director Allen Patricia L

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 632d
  SEC Form 4 filed by Director Boylan James P

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 632d
  SEC Form 4 filed by Chief Commercial Officer Oliveira Orlando

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 632d
  SEC Form 4 filed by Officer Farmer Joseph L

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 632d
  SEC Form 4 filed by Officer Fox Jennifer A.

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 632d
  Chief Executive Officer Moulder Leon O Jr converted options into 693,175 shares (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)

Other ZBIO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends